SCHEMBL5690271

SCHEMBL5690271

CN(CCCc1ccccc1)C1CCC(c2ccc(N)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
GRIN2B Q13224 5/20 0.51
GRIN1 Q05586 2/20 0.49
SPHK1 Q9NYA1 1/20 0.48
SLC18A3 Q16572 1/20 0.48
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47
OPRK1 P41145 1/20 0.47
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
AOC3 Q16853 1/20 0.45
MAOB P27338 2/20 0.45
CHIT1 Q13231 1/20 0.44
CHIA Q9BZP6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5690277 1.00 KDM4E (0.52) KDM4EGRIN2BGRIN1SPHK1SLC18A3
SCHEMBL5689661 0.87 KDM4E (0.52) KDM4EGRIN2BGRIN1SPHK1SLC18A3
SCHEMBL7023319 0.87 KDM4E (0.52) KDM4EGRIN2BGRIN1SPHK1SLC18A3
SCHEMBL5689666 0.87 KDM4E (0.52) KDM4EGRIN2BGRIN1SPHK1SLC18A3
SCHEMBL5691626 0.83 BCHE (0.49) KDM4EGRIN2BGRIN1SPHK1SLC18A3
SCHEMBL5691624 0.83 BCHE (0.49) KDM4EGRIN2BGRIN1SPHK1SLC18A3
SCHEMBL5689914 0.82 KDM4E (0.47) KDM4EGRIN2BGRIN1SPHK1SLC18A3
SCHEMBL5689912 0.82 KDM4E (0.47) KDM4EGRIN2BGRIN1SPHK1SLC18A3
SCHEMBL6841392 0.82 KDM4E (0.56) KDM4EGRIN2BGRIN1SPHK1SLC18A3
SCHEMBL6836225 0.82 KDM4E (0.56) KDM4EGRIN2BGRIN1SPHK1SLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0982026-B1 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers HOFFMANN LA ROCHE (CH) 2006-05-17 EP disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed